Hitachi has received a roughly 10 billion yen ($93.8 million) order for an advanced cancer therapy system from a Taiwan hospital, its first overseas sale of heavy-ion therapy.
The Japanese conglomerate announced Wednesday that it won the order from Taipei Veterans General Hospital. Delivery is expected in 2021 or 2022.
The treatment is a type of particle therapy in which carbon ions are accelerated up to 70% of the speed of light and directly targeted at the tumor. The patient experiences little pain during the treatment, and there are few side effects compared with traditional radiation therapy.